Bio-Rad Laboratories Inc (BIO)
325.58
+1.89
(+0.58%)
USD |
NYSE |
Nov 21, 16:00
326.10
+0.52
(+0.16%)
Pre-Market: 08:58
Bio-Rad Laboratories Net Income (Quarterly): 653.17M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 653.17M |
| June 30, 2024 | -2.165B |
| March 31, 2024 | 383.92M |
| December 31, 2023 | 349.71M |
| September 30, 2023 | 106.26M |
| June 30, 2023 | -1.162B |
| March 31, 2023 | 68.96M |
| December 31, 2022 | 827.73M |
| September 30, 2022 | -162.81M |
| June 30, 2022 | -925.11M |
| March 31, 2022 | -3.367B |
| December 31, 2021 | -1.565B |
| September 30, 2021 | 3.928B |
| June 30, 2021 | 914.11M |
| March 31, 2021 | 977.41M |
| December 31, 2020 | 847.06M |
| September 30, 2020 | 1.315B |
| June 30, 2020 | 966.43M |
| March 31, 2020 | 685.91M |
| December 31, 2019 | 553.49M |
| September 30, 2019 | -258.82M |
| June 30, 2019 | 598.81M |
| March 31, 2019 | 865.20M |
| December 31, 2018 | -828.53M |
| September 30, 2018 | 269.33M |
| Date | Value |
|---|---|
| June 30, 2018 | 268.04M |
| March 31, 2018 | 656.77M |
| December 31, 2017 | 82.73M |
| September 30, 2017 | 22.07M |
| June 30, 2017 | 5.035M |
| March 31, 2017 | 12.41M |
| December 31, 2016 | -22.70M |
| September 30, 2016 | 18.40M |
| June 30, 2016 | 18.01M |
| March 31, 2016 | 12.28M |
| December 31, 2015 | 45.63M |
| September 30, 2015 | 17.37M |
| June 30, 2015 | 28.42M |
| March 31, 2015 | 17.82M |
| December 31, 2014 | 39.04M |
| September 30, 2014 | 11.51M |
| June 30, 2014 | 31.63M |
| March 31, 2014 | 6.668M |
| December 31, 2013 | 30.14M |
| September 30, 2013 | -7.099M |
| June 30, 2013 | 34.60M |
| March 31, 2013 | 20.15M |
| December 31, 2012 | 43.25M |
| September 30, 2012 | 42.63M |
| June 30, 2012 | 48.34M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-3.367B
Minimum
Mar 2022
3.928B
Maximum
Sep 2021
161.44M
Average
468.70M
Median
Net Income (Quarterly) Benchmarks
| Agilent Technologies Inc | 282.00M |
| Bruker Corp | 40.90M |
| Azenta Inc | -4.984M |
| Harvard Bioscience Inc | -4.802M |
| Bionano Genomics Inc | -44.25M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 649.73M |
| Total Expenses (Quarterly) | 585.26M |
| EPS Diluted (Quarterly) | 23.34 |
| Enterprise Value | 8.694B |
| Gross Profit Margin (Quarterly) | 54.78% |
| Earnings Yield | -8.39% |
| Operating Earnings Yield | 3.31% |
| Normalized Earnings Yield | 2.897 |